Controversies in Clinical Transfusion from the Transfusion Alliance: Does Red Blood Cell Transfusion Increase Mortality? and Component Therapy in the Era of New Anticoagulants and Antiplatelet Drugs
Program Code: 311-TC
Monday, October 25, 2004
8:30 AM to 12:00 PM (ET)

SPEAKERS
Gus J. Vlahakes, MD, Massachusettes General Hospital
Lawrence Goodnough, MD, Stanford University Medical Center
Lena M. Napolitano, MD, FACS, FCCP, FCCM, University of Michigan
Kenneth Bauer, MD, VA Boston Healthcare System
Robert Thurer, MD, Harvard Medical School Dubai Center
Walter Dzik, MD, Mass General Hospital

DESCRIPTION
Using brief oral presentations, the Transfusion Alliance will discuss two topics: "Does Red Blood Cell Transfusion Increase Mortality?" and "Component Therapy in the Era of New Anticoagulants and Antiplatelet Drugs." The presentations will be followed by a lively panel discussion and a question and answer period.

OBJECTIVES

• Incorporate knowledge of the risks, benefits and outcomes of transfusion therapy and improve transfusion practice
• Collaborate with clinicians involved in difficult transfusion decisions
• Explain the use of new antiplatelet and anticoagulant drugs and their impact on component transfusion

AUDIENCE
Physicians, Technologists, Nurses, Managers/Supervisors

PROGRAM LEVEL
Intermediate to Advanced